Delayed SEC reports
Compare what managers reported this quarter with last quarter. These reports are delayed.Large US investment managers report many holdings every quarter. We compare the shares they reported this quarter with the prior quarter. The reports arrive late and do not show the exact trade day, trade price, shorts, cash, or the manager’s reason.
15 of 16 managers have a matching row in their newest complete report.
$875.10 B total reported value across 13575 holdings · 13F-HR · filed Aug 14, 2026 · open SEC report ↗
How to read this manager
Citadel often reports shares, calls, and puts at the same time. These rows show reported exposure, not a simple bullish or bearish bet.
TickerYou therefore keeps this manager out of the group direction ranking, while preserving its common-share and option rows here for investigation.
These managers' newest complete report is at least 2 quarters behind the newest period above. They remain available for history, but are kept separate from managers with newer reports.
For the matching rows, compared with Q1 2026, the Q2 2026 report's stock rows show 38 new positions, 62 positions with more shares reported, 67 positions with fewer shares reported, and 23 positions that no longer appear.
Green + ▲ means new or more shares; red + ▼ means fewer shares or no longer listed. The words and dot count repeat the meaning without relying on colour. Fewer shares or no listing does not mean the manager opened a short position.
Kept outside those common-share counts: 227 option-contract rows, 5 principal-amount positions.
13F reports can arrive up to 45 days after quarter-end, so this comparison is not proof of when, why, or at what price the manager traded.
Green means the manager reported a new or larger share amount. Red means a smaller amount or the stock was no longer listed. This compares two delayed reports; it does not show the exact trade.
Biggest reported changes — ranked by position value. The bar is the position's size against the largest one shown; the figure under it is the difference in the filed SH or principal amount. Corporate actions are not normalized.
Absent from latest filing — a 13F reports only that the position is absent, not when, why, or for what proceeds it changed. The prior SH or principal amount is printed, but these rows are not ranked because those units are not comparable.
PUT and CALL are contract labels, not common-share holdings. A 13F reports these option rows but does not establish whether the strategy is bullish, bearish, hedged, or part of a spread. It also does not reveal strike, expiry, premium, or the rest of the manager's book.
217 more option comparison rows in this filing.
These rows use PRN amounts, not share counts, and are excluded from common-share comparisons.
| Position | Value | Filed amount | Change |
|---|---|---|---|
SEC issuerMILESTONE PHARMACEUTICALS IN | $44,0690.0% of filing | 32,887 sh | FEWER SHARES |
| $42,8650.0% of filing | 22,210 sh | NEW THIS QUARTER | |
| $40,9080.0% of filing | 21,306 sh | NEW THIS QUARTER | |
| $40,4300.0% of filing | 26,084 sh | FEWER SHARES | |
SEC issuer60 DEGREES PHARMACEUTICALS I | $39,3570.0% of filing | 22,362 sh | NEW THIS QUARTER |
SEC issuerMETALPHA TECHN HOLDING LTD | $29,3630.0% of filing | 30,428 sh | FEWER SHARES |
| $29,2310.0% of filing | 17,716 sh | NEW THIS QUARTER | |
| $25,2620.0% of filing | 95,258 sh | MORE SHARES | |
SEC issuerINNATE PHARMA S A | $22,8910.0% of filing | 12,441 sh | NEW THIS QUARTER |
| $18,1350.0% of filing | 12,090 sh | NEW THIS QUARTER | |
| $17,6630.0% of filing | 18,661 sh | NEW THIS QUARTER | |
| $16,9800.0% of filing | 13,266 sh | NEW THIS QUARTER | |
| $14,0160.0% of filing | 55,182 sh | NEW THIS QUARTER | |
| $11,2030.0% of filing | 25,102 sh | MORE SHARES | |
SEC issuerMATINAS BIOPHARMA HLDGS INC | $9,4650.0% of filing | 15,465 sh | FEWER SHARES |
| $6,1920.0% of filing | 56,089 sh | FEWER SHARES | |
SEC issuerPHAOS TECHNOLOGY HLDGS (CAYM | $4,5760.0% of filing | 16,400 sh | NEW THIS QUARTER |
| $1,9240.0% of filing | 310,370 sh | MORE SHARES |